Unilever (UL) is Pruning Its Portfolio. Could That Unlock Growth?

Unilever’s Zwitsal divestment supports portfolio simplification, allowing greater focus on global Power Brands, while concentration in premium categories and execution risks remain key considerations.

Unilever PLC (NYSE:UL) announced on September 17 the sale of its personal care and baby care brand, Zwitsal, to Dutch manufacturer Royal Sanders for an undisclosed financial figure. The divestment directly aligns with management’s operational mandate to streamline its organizational focus around global Power Brands that possess international scale. Because Zwitsal’s presence is predominantly regional, concentrated heavily within the Netherlands and Belgium, it falls outside Unilever’s core growth roadmap. The corporate pruning follows a strong H1 2026 performance where Unilever achieved 4.8% underlying sales growth (USG) with 4.2% underlying volume growth, expanding underlying operating margin by 10 bps to 20.3% on turnover of €25.6 billion.

You May Also Want To Read: e.l.f. Beauty(ELF) & Ulta Beauty (ULTA): Rhode Is Carrying e.l.f. Beauty. Ulta Is Winning on Rich Shoppers Instead

Unilever (UL) Looked Undervalued. Why Was It Sold?

Bull Case

The sale of Zwitsal serves as a clear proof point of Unilever PLC’s disciplined portfolio rationalization. By shedding non-core, localized assets, management can reallocate marketing, R&D, and operational resources toward its 30 core Power Brands, which accounted for 78% of group turnover and delivered superior performance with 6.0% USG and 5.4% volume growth in H1 2026. This focus reinforces the structural acceleration observed across key divisions, such as Beauty & Wellbeing (5.9% USG) and Personal Care (4.8% USG).

Furthermore, pruning minor local lines enables the company to direct capital toward higher-margin, scalable categories following the completion of its €800 million productivity program ahead of schedule. Globally, favorable regulatory developments, such as expected GST simplifications in India, and the planned demerger of its Foods unit (following the McCormick operating model update) further sharpen Unilever’s focus on faster-growing, high-return personal care and wellness segments.

Bear Case

While shedding secondary regional brands removes minor operational drag, it simultaneously increases Unilever’s concentration risk and relies heavily on flawless execution across its primary growth drivers. With local mainstays being trimmed, overall group volume expansion becomes increasingly reliant on high-margin segments like Prestige Beauty and Health & Wellbeing.

This concentration exposes investors to performance dips in premium retail channels. Any lingering weakness or sub-par performance in prestige brands like Dermalogica and Paula’s Choice risks eroding overall pricing power and demanding elevated promotional spend to defend market share. If prestige growth lags, portfolio optimization alone cannot offset channel softness, potentially delaying long-term margin improvement targets.

Don’t Miss: Colgate-Palmolive Seeks Value Through Portfolio Reshaping

Market Sentiment & Conclusion

Market sentiment surrounding Unilever PLC remains overall positive as management continues executing its strategy of volume-led growth and aggressive strategic sharpening. Management upgraded its full-year 2026 outlook, projecting underlying sales growth within its multi-year guidance range of 4% to 6%, alongside modest operating margin expansion over 2025’s 20.0%. In conclusion, the divestment of Zwitsal is a structurally logical, value-accretive step. It liquidates a hyper-regional asset to double down on high-performing Power Brands, reinforcing Unilever’s ongoing transition toward a leaner, faster-growing, and higher-margin consumer goods franchise.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Follow Insider Monkey on Google News.